Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
June 08 2017 - 3:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a
corporate update at the Goldman Sachs 38th Annual Global Healthcare
Conference on Thursday, June 15, 2017 at 10:00 a.m. Pacific Time
(1:00 p.m. Eastern Time) at the Terranea Resort in Rancho Palos
Verdes, California.
A live webcast of Ironwood’s presentation will be accessible
through the Investors section of the company’s website at
www.ironwoodpharma.com. To access the webcast, please log on to the
Ironwood website approximately 15 minutes prior to the start time
to ensure adequate time for any software downloads that may be
required. A replay of the webcast will be available on Ironwood’s
website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is a commercial
biotechnology company focused on creating medicines that make a
difference for patients, building value for our fellow
shareholders, and empowering our passionate team. We are
commercializing two innovative primary care products: linaclotide,
the U.S. branded prescription market leader for adults with
irritable bowel syndrome with constipation (IBS-C) or chronic
idiopathic constipation (CIC), and lesinurad, which is approved to
be taken with a xanthine oxidase inhibitor (XOI) for the treatment
of hyperuricemia associated with uncontrolled gout. We are also
advancing a pipeline of internally and externally generated
innovative product candidates in areas of significant unmet need,
including uncontrolled gastroesophageal reflux disease and vascular
and fibrotic diseases. Ironwood was founded in 1998 and is
headquartered in Cambridge, Mass. For more information, please
visit www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170608005858/en/
Ironwood Pharmaceuticals, Inc.Media RelationsTrista Morrison,
617-374-5095Director, Corporate
Communicationstmorrison@ironwoodpharma.comorInvestor
RelationsMeredith Kaya, 617-374-5082Senior Director, Investor
Relationsmkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Apr 2024 to May 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From May 2023 to May 2024